Ben Lauing, Imaging Performance Partnership
Released yesterday, the third edition of the American College of Chest Physicians (ACCP) Diagnosis and Management of Lung Cancer guidelines includes the recommendation that providers offer annual low-dose CT scans for patients at high risk.
While the ACCP introduced this recommendation last year, its inclusion in the updated guidelines further validates the clinical utility of CT in the diagnosis of lung cancer. This official acknowledgement may be welcome news to imaging providers who face flat or declining volumes and seek new opportunities for growth.
New screening guidelines indicate CT for lung cancer
Stephanie Krent, Imaging Performance Partnership
New developments in lung cancer CT screening have given many hope that doctors can find the disease, responsible for over one million deaths annually, early enough to successfully treat it. But widespread implementation of screening programs hinges on the determination of high-risk patient populations.
Now, researchers from the Liverpool Lung Project believe their risk stratification model can bridge the gap.
Liverpool Lung Project: A new way to personalize cancer risk
Emily Hague, Imaging Performance Partnership
A recent study, published in this month’s Radiology, examined the effectiveness of PET/MR in staging lung cancer, compared with more commonly used PET/CT.
The researchers, from Eberhard-Karls University in Tübingen, Germany, found that PET/MR produced diagnostic-quality images and concluded PET/MR has potential to replace PET/CT as the modality of choice—resulting in a 75% reduction radiation exposure.
PET/MR: As good as PET/CT without the risk?